Jim Palma: Feeling grateful for another successful TargetCancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers this week
Jim Palma, Chief Executive Officer of the TargetCancer Foundation, recently shared on LinkedIn:
“Feeling grateful for another successful TargetCancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers this week! Amazing to have so many good friends and colleagues together for such an impactful day of discussions. My sincere thanks to all of our speakers, guests, and sponsors for making this event possible!
Special thanks to Katie Ortman Doble for providing such a powerful patient perspective to start the day, Vivek Subbiah, MD for providing our Scientific Keynote, and Razelle Kurzrock for our very first public presentation of data from the TRACK study, and for leading our live Molecular Tumor Board session.
Planning for the 2024 Think Tank starts soon, so stay tuned for more details!”
Source: Jim Palma/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023